Cargando…
New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
Skin cutaneous melanoma (SKCM) is the most aggressive and fatal type of skin cancer. Its highly heterogeneous features make personalized treatments difficult, so there is an urgent need to identify markers for early diagnosis and therapy. Detailed profiles are useful for assessing malignancy potenti...
Autores principales: | Zhou, Sitong, Han, Yuanyuan, Li, Jiehua, Pi, Xiaobing, Lyu, Jin, Xiang, Shijian, Zhou, Xinzhu, Chen, Xiaodong, Wang, Zhengguang, Yang, Ronghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548670/ https://www.ncbi.nlm.nih.gov/pubmed/34722301 http://dx.doi.org/10.3389/fonc.2021.745384 |
Ejemplares similares
-
TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM)
por: Zhou, Sitong, et al.
Publicado: (2022) -
The Identification of the Metabolism Subtypes of Skin Cutaneous Melanoma Associated With the Tumor Microenvironment and the Immunotherapy
por: Yang, Ronghua, et al.
Publicado: (2021) -
Identification and Verification of Five Potential Biomarkers Related to Skin and Thermal Injury Using Weighted Gene Co-Expression Network Analysis
por: Yang, Ronghua, et al.
Publicado: (2022) -
The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Zhou, Sitong, et al.
Publicado: (2021) -
UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
por: Zhou, Sitong, et al.
Publicado: (2021)